Peer-reviewedCC BY-NC-NDHemaSphere
Human erythroid models of sickle cell disease
- 1University of Bristol
- 2Institut IMAGINE, INSERM UMR1163
- 3School of Cancer and Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College Hospital
Related
- Probing Red Blood Cell Deformability in Sickle Cell Disease, Sickle Cell Trait, and Healthy Controls by Ektacytometry
- Anemia in a Cohort of Greek Patients with Sickle Cell Disease: Clinical Insights and Therapeutic Challenges
- Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews
- Platelets in sickle cell disease: biomarkers, mediators, and lessons from clinical trials
- India's indigenous CRISPR-based gene-editing therapy for sickle cell disease: innovation to equitable implementation.
BibTeX
@article{daniels2026human,
title = {{Human erythroid models of sickle cell disease}},
author = {Deborah E. Daniels and Maria A. Lizarralde‐Iragorri and Fatima O. Oyawoye and David C. Rees and Jan Frayne and Sara El Hoss},
journal = {HemaSphere},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13671357},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Human erythroid models of sickle cell disease
AU - Deborah E. Daniels
AU - Maria A. Lizarralde‐Iragorri
AU - Fatima O. Oyawoye
AU - David C. Rees
AU - Jan Frayne
AU - Sara El Hoss
PY - 2026
DA - 2026/10/01
JO - HemaSphere
UR - https://europepmc.org/article/PMC/PMC13671357
SN - 2572-9241
ER -